Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.

Zabludoff SD, Deng C, Grondine MR, Sheehy AM, Ashwell S, Caleb BL, Green S, Haye HR, Horn CL, Janetka JW, Liu D, Mouchet E, Ready S, Rosenthal JL, Queva C, Schwartz GK, Taylor KJ, Tse AN, Walker GE, White AM.

Mol Cancer Ther. 2008 Sep;7(9):2955-66. doi: 10.1158/1535-7163.MCT-08-0492.

2.

Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin.

Caleb BL, Hardenbrook M, Cherington V, Castellot JJ Jr.

J Cell Physiol. 1996 May;167(2):185-95.

PMID:
8613458
3.
5.

Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.

Pukac LA, Castellot JJ Jr, Wright TC Jr, Caleb BL, Karnovsky MJ.

Cell Regul. 1990 Apr;1(5):435-43.

6.

Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells.

Castellot JJ Jr, Pukac LA, Caleb BL, Wright TC Jr, Karnovsky MJ.

J Cell Biol. 1989 Dec;109(6 Pt 1):3147-55. Erratum in: J Cell Biol 1990 Mar;110(3):863.

7.

Binding and internalization of heparin by vascular smooth muscle cells.

Castellot JJ Jr, Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ.

J Cell Physiol. 1985 Jul;124(1):13-20.

PMID:
3930515

Supplemental Content

Loading ...
Support Center